Background And Objective: To report on the microbiology, management, and visual outcomes of intravitreal injection (IVI)-associated, culture-proven endophthalmitis.

Patients And Methods: All patients seen at a tertiary referral center with culture-proven endophthalmitis associated with an IVI between June 2007 and July 2017 were included in this retrospective analysis.

Results: Thirty-five patients with culture-positive endophthalmitis following IVI were identified. All gram-positive organisms (34 of 35) were susceptible to vancomycin. Cases due to pathogens associated with oral or respiratory flora were common (31.4%, n = 11), presented earlier (2.0 days vs. 4.6 days, P < .001), were more likely to undergo pars plana vitrectomy (81.8% vs. 25.0%, P = .002) and had worse visual acuity outcomes.

Conclusion: IVI-associated endophthalmitis pathogens and anti-microbial susceptibilities in the Pacific Northwest are similar to those reported from other geographic locations. Bacteria associated with the oral and respiratory flora are common isolates that result in a more aggressive course and worse visual outcomes. [Ophthalmic Surg Lasers Imaging Retina. 2019;50:33-38.].

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875494PMC
http://dx.doi.org/10.3928/23258160-20181212-05DOI Listing

Publication Analysis

Top Keywords

culture-proven endophthalmitis
8
intravitreal injection
8
visual outcomes
8
associated oral
8
oral respiratory
8
respiratory flora
8
flora common
8
worse visual
8
endophthalmitis intravitreal
4
injection 10-year
4

Similar Publications

Purpose: To report an incidence of procedure-related complications in preterm infants with retinopathy of prematurity (ROP) treated with intravitreal anti-VEGFs injection in both eyes on the same day.

Design: Retrospective, multicenter case series.

Subjects: Preterm infants with ROP treated with anti-VEGF bilaterally on the same day.

View Article and Find Full Text PDF

Aim: We report a unique finding of iris nodules in a woman with endogenous endophthalmitis due to with no history of ocular surgery or trauma and good visual outcome.

Materials & Methods: Retrospective case report.

Results: A 39-year-old woman with a history of type 2 diabetes mellitus presented with a decrease in vision in the right eye of 1-month duration.

View Article and Find Full Text PDF

Endophthalmitis Caused by : Clinical Characteristics, Outcomes and Antibiotic Susceptibility.

Antibiotics (Basel)

July 2024

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China.

endophthalmitis is a severe vision-threatening disease. This study aimed to analyze the clinical characteristics, antibiotic susceptibility, and risk factors for poor final visual acuity (VA) and enucleation or evisceration (ENEV) outcomes of endophthalmitis patients. We retrospectively reviewed 52 cases (52 eyes) of culture-proven endophthalmitis at Zhongshan Ophthalmic Center from January 2013 to December 2023.

View Article and Find Full Text PDF

Background: To evaluate the clinical profile, outcomes and antibiotic resistance in bacterial endophthalmitis.

Methods: This was a post-hoc analysis of a study conducted at a tertiary centre, where 60 consecutive cases of culture-proven bacterial endophthalmitis were included prospectively. Group 1 included coagulase-negative Staphylococcus endophthalmitis (CNSE), while group 2 included the remaining cases.

View Article and Find Full Text PDF

Endophthalmitis is an uncommon purulent inflammation of the intraocular fluids secondary to endogenous or exogenous causes. It is known that posttraumatic endophthalmitis had a notably poor visual outcome, and it poses therapeutic challenges. Therefore, early organism detection would be beneficial in therapeutic management and are able to reduce long-term complications.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!